New Diagnostic Tools For Alzheimer Disease

Abstract

The present invention relates to development, validation and application of new sets of bio markers for diagnosis of Alzheimer's disease (AD) and related disorders including early diagnosis of MCI and early prodrome of AD, identification of disease sub types, prediction of their response to disease management procedures, drugs and their combinations and for monitoring response for these treatment, including validation of biomarkers for clinical trials.


Claims

Download Citation


Sign in to the Lens

Feedback